DexCom (NasdaqGS:DXCM) reported new clinical data from its CONNECT trial on the Dexcom G7 continuous glucose monitoring system in adults with Type 2 diabetes not using insulin. The company introduced ...

June 11 (Reuters) - Drug wholesaler Pharmsource LLC said it was unaware the Dexcom glucose sensors it bought from licensed ...

New study results could lead to better insurance coverage of the devices for people who don’t take insulin, a researcher said ...

DexCom trades at $74.63 per share and has stayed right on track with the overall market, gaining 8.3% over the last six ...

Oura Ring uses Stelo by Dexcom to show glucose patterns, meal responses, and Time Above Range for users tracking blood sugar ...

The company routinely scraps sensors that do not meet its standards. The sensors are sent to a third-party vendor for destruction and recycling. Dexcom said it traced sales of the ...

By Sneha S K June 6 (Reuters) - Medical device maker Dexcom said the use of its continuous glucose monitor, G7, led to ...

Dexcom says stolen G7 sensors from two scrapped lots were sold through unauthorized channels, creating infection and reading-failure risks.

Through independent moderation by Vital Findings, council members reinforced that Dexcom remains a life-changing, essential ...

DXCM banks on CGM market growth, expanding international demand and strong Q1 momentum, though competitive pressures remain a ...

DexCom posts steady profits and global reach, while Insulet surges ahead with rapid revenue growth and a focused product line ...

Health tech startup Signos announced a $20 million funding round Wednesday, including an expanded partnership with medical device giant Dexcom.